Loading…
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
COPE Act of 2019, HR 1528, Reduction and reforms to 340B, provider status for pharmacists, surprise medical billing, sustainability of safety net health systems
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
THE METROHEALTH SYSTEM via THE METROHEALTH SYSTEM
2019 · fourth_quarter · 4T
Reduction and reforms to Medicaid DSH, 340B surprise medical billing, sustainability of safety net health systems
funding for Medicaid DSH, Medicare site neutrality policies, 340B, Social Determinants of Health
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Source: Senate LDA
2019 · third_quarter · Q3
funding for Medicaid DSH, Medicare site neutrality policies, 340B, Social Determinants of Health
Reduction and reforms to Medicaid DSH, 340B surprise medical billing, sustainability of safety net health systems
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
THE METROHEALTH SYSTEM via THE METROHEALTH SYSTEM
2019 · second_quarter · Q2
COPE Act of 2019, HR 1528, Reduction and reforms to 340B, provider status for pharmacists, surprise medical billing, sustainability of safety net health systems
funding for Medicaid DSH, Medicare site neutrality policies, and Medicare graduate medical education funding
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
THE METROHEALTH SYSTEM via THE METROHEALTH SYSTEM
2019 · first_quarter · Q1
340B, HOPD, GME, DSH
Opioid Policy
340B, drug pricing transparency
Filing targets: HOUSE OF REPRESENTATIVES, SENATE